NL-OMON52251招募中不适用
*Differences in effect of treatment with mepolizumab and benralizumab on resident and inflammatory eosinophils - DIMENSIO
niversitair Medisch Centrum Utrecht0 个研究点目标入组 72 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •Age >= 18
- •Diagnosis of severe refractory eosinophilic asthma
- •Eligible for mepolizumab or benralizumab therapy according the national
- •recommendations for severe asthma of the Dutch society for lung diseases and
- •tuberculosis (NVALT guideline 2013): Patients with asthma, forwhom alternative
- •diagnoses are excluded, comorbidity optimally treated, provoking factors
- •minimized and therapy compliance optimized, but despite this still have
- •insufficient asthma control (>= 1.5 ACQ-7 or other questionnaire) or frequent
- •(>=2 annually) severe exacerbations (systemic CS needed) while routinely using
- •highdose asthma medication (>= 1000 mcg/day fluticasone propionate equivalent
- •and/or daily OCS in combination with LABA or other controller medication); or
- •patients who can achieve asthma control only with systemic CS and are therefore
- •are risk for adverse effects or the corticosteroids.
- •Treated with mepolizumab or benralizumab for at least 4 months.
- •Before treatment with biologics a blood eosinophilia (>= 150
- •eosinophils/microl blood) irrespective of steroid use
- •Inclusion criteria healthy controls
- •Age >= 18 and matching age and sex of the population of asthma patients
排除标准
- •Any infection (eg. HIV, Hepatitis, STDs)
- •Insulin dependent diabetes
- •Smoking at present or in the last 12 months and/or a past history of more
- •than 10 pack years
- •Proven allergic bronchopulmonary aspergillosis
- •Auto-immune diseases
- •Use of medication, excluding:
- •o Anticonceptives
- •o Pain killers, if used on average less than once a week
- •o acetylsalicylic acid 0-2 days before the start of the study
- •exuberant alcohol consumption (for males > 36 glasses per week, for females
- •>24 glasses per week)
- •History of cancer
- •Use of biologicals other than mepolizumab or benralizumab
- •daily oral steroid therapy during the three months preceding inclusion
研究者
相似试验
撤回
不适用
*Differences in effect of treatment with mepolizumab and benralizumab on resident and inflammatory eosinophils.shortness of breath1000170810006436asthmaNL-OMON49549niversitair Medisch Centrum Utrecht72
尚未招募
不适用
A clinical study comparing remimazolam and propofol during laparoscopic cholecystectomy.Diseases of the digestive systemKCT0006702Dong-A University108
招募中
1 期
The effect of Royal jelly on ovulation induction cycles in infertile women with polycystic ovary syndromePolycystic ovarian syndrome +infertility.Polycystic ovarian syndromeE28.2IRCT20220401054383N1Vice-Chancellor's Office for Research of Sabzevar univercity110
招募中
3 期
The effect of midazolam on the improvement of hysteria symptomsHysterical patients.Dissociative and conversion disordersIRCT20220516054869N4Zahedan University of Medical Sciences80
尚未招募
3 期
The comparison of effectiveness of treatment of manipulation of shoulder under block of sensation around shoulder followed by physiotherapy versus physiotherapy alone in treatment of primary adhesive capsulitisCTRI/2020/09/027826ALL INDIA INSTITUTE OF MEDICAL SCIENCES NEW DELHI